Brickell Biotech, Inc. – NASDAQ:BBI

Add to watchlist

$2.35

+0.38

+19.29%

Market open

Closed in about 3 hours

+43.80%

month

-11.66%

quarter

+681.75%

year

Market Cap	7.08M
Enterprise value	N/A

P/E	-5.59
EV/Sales	-1.76
EV/EBITDA	0.27
Price/Sales	1.34
Price/Book	0.39
PEG ratio	-0.13
EPS	-13.66

Revenue	4.64M
EBITDA	-29.83M
Income	-29.88M
Revenue Q/Q	2757.61%
Revenue Y/Y	1277.74%

Profit margin	-643.48%
Oper. margin	-657.53%
Gross margin	0%
EBIT margin	-657.53%
EBITDA margin	-642.67%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Brickell Biotech, Inc. (NASDAQ:BBI): Profit margin
Sep 2021	132K	-13.25M	-10040.15%
Dec 2021	104K	-6.07M	-5837.5%
Mar 2022	92K	-9.41M	-10232.61%
Jun 2022	4.31M	-1.14M	-26.63%

Brickell Biotech, Inc. (NASDAQ:BBI): Earnings per share (EPS)
2021-11-09	-4.95	-7.2
2022-03-15	-3.6	-2.7
2022-05-12	-2.7	-3.6
2022-08-11	-1.44	-0.01

Brickell Biotech, Inc. (NASDAQ:BBI): Debt to assets
Sep 2021	24188000	4.22M	17.45%
Dec 2021	29717000	4.81M	16.19%
Mar 2022	20789000	4.74M	22.81%
Jun 2022	18507000	2.87M	15.51%

Brickell Biotech, Inc. (NASDAQ:BBI): Cash Flow
Sep 2021	-11.14M	0	8.12M
Dec 2021	-4.79M	36K	10.29M
Mar 2022	-9.54M	0	-55K
Jun 2022	-2.96M	0	160K

Brickell Biotech alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Brickell Biotech, Inc. (NASDAQ:BBI): Employee count
Aug 2023	16
Sep 2023	16
Oct 2023	16
Nov 2023	16
Dec 2023	16
Jan 2024	16
Feb 2024	16
Mar 2024	16
Apr 2024	16
May 2024	16
Jun 2024	16
Jul 2024	16

Brickell Biotech
Insider Trading

Brickell Biotech, Inc. (NASDAQ:BBI): Insider trades (number of shares)
Period	Buy	Sel
Sep 2020	52526	0
Mar 2021	100000	0
May 2021	57177	0
Jul 2021	218124	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	26 Jul 2021	HARDY REGINALD L director, officer: Chairman of the Board director, officer: Chairman of ..	Common Stock	100,000	$0.67	$67,400
Purchase	23 Jul 2021	MCAVOY DAVID R. officer: General Counsel and CCO officer: General Counsel and CCO	Common Stock	18,124	$0.67	$12,143
Purchase	23 Jul 2021	HARDY REGINALD L director, officer: Chairman of the Board director, officer: Chairman of ..	Common Stock	100,000	$0.67	$67,400
Purchase	19 May 2021	CHADHA DEEPAK officer: Chief Re..	Common Stock	12,500	$0.83	$10,375
Purchase	18 May 2021	CHADHA DEEPAK officer: Chief Re..	Common Stock	2,700	$0.82	$2,211
Purchase	17 May 2021	MCAVOY DAVID R. officer: General Counsel and CCO officer: General Counsel and CCO	Common Stock	26,602	$0.8	$21,282
Purchase	17 May 2021	SKLAWER ANDREW D officer: COO and ..	Common Stock	15,375	$0.8	$12,300
Option	16 Mar 2021	SKLAWER ANDREW D officer: COO and ..	Common Stock	20,000	N/A	N/A
Option	16 Mar 2021	SKLAWER ANDREW D officer: COO and ..	Restricted Stock Units	20,000	N/A	N/A
Option	16 Mar 2021	MCAVOY DAVID R. officer: General Counsel and CCO officer: General Counsel and CCO	Common Stock	25,000	N/A	N/A

BBI insider trading transactions

Status	Patent	Filling date	Issue date
Application	Application CRYSTALLINE FORM OF SOFPIRONIUM BROMIDE AND PREPARATION METHOD THEREOF Filling date: 30 Jun 2021 Issue date: 23 Dec 2021	30 Jun 2021	23 Dec 2021
Application	Application APPLICATOR AND SYSTEM FOR PHARMACEUTICAL PREPARATION AND METHOD OF USE Filling date: 10 May 2019 Issue date: 17 Jun 2021	10 May 2019	17 Jun 2021
Application	Application CRYSTALLINE FORM OF SOFPIRONIUM BROMIDE AND PREPARATION METHOD THEREOF Filling date: 25 Nov 2020 Issue date: 10 Jun 2021	25 Nov 2020	10 Jun 2021

Brickell Biotech
Earnings Call Transcripts

Quarter	Transcript
Q2 2022 11 Aug 2022	Q2 2022 Earnings Call Transcript
Q1 2022 12 May 2022	Q1 2022 Earnings Call Transcript
Q4 2021 15 Mar 2022	Q4 2021 Earnings Call Transcript
Q3 2021 9 Nov 2021	Q3 2021 Earnings Call Transcript

BBI earnings call transcripts

Brickell Biotech
Executives

Insider	Age	Compensation
Attorney Robert Busard Brown (1962) Chief Executive Officer & Director	63	$711,000
Mr. Andrew D. Sklawer (1985) Co-Founder, Chief Operating Officer & Sec.	40	$492,500
Mr. Deepak Chadha (1970) Chief R&D Officer	55	$479,830
Mr. Reginald L. Hardy M.B.A., R.Ph. (1958) Co-Founder & Chairman	67	$74,000

Brickell Biotech
Latest News

Thursday, 12 December 2024
16:01	Boundless Bio Announces Pipeline and Leadership Updates	globenewswire.com
Thursday, 7 November 2024
16:01	Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights	globenewswire.com
Friday, 1 December 2023
17:00	Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders	globenewswire.com
Friday, 17 November 2023
08:30	Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders	globenewswire.com
Monday, 13 November 2023
08:30	Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update	globenewswire.com
Thursday, 3 November 2022
16:05	Fresh Tracks Therapeutics to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10, 2022	GlobeNewsWire
Thursday, 11 August 2022
18:27	Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q2 2022 Results - Earnings Call Transcript	Seeking Alpha
Friday, 1 July 2022
15:44	Brickell Biotech (BBI) Stock: 1-For-45 Reverse Split Announced	Pulse2
Wednesday, 29 June 2022
15:02	Brickell Biotech (BBI) Stock Gains 50% Ahead of Meeting to Prevent Delisting	InvestorPlace
10:03	3 Penny Stocks To Watch After GDP Report	PennyStocks
Thursday, 9 June 2022
19:20	Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now	PennyStocks
Thursday, 12 May 2022
18:48	Brickell (BBI) Reports Q1 Loss, Lags Revenue Estimates	Zacks Investment Research
18:35	Brickell Biotech, Inc.'s (BBI) CEO Robert Brown on Q1 2022 Results - Earnings Call Transcript	Seeking Alpha
Saturday, 7 May 2022
11:30	3 Strategies You Need to Know For Buying Penny Stocks	PennyStocks
Thursday, 5 May 2022
16:01	Brickell Biotech to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12, 2022	GlobeNewsWire
Wednesday, 4 May 2022
06:50	Brickell Biotech Shares Surge After Offloading Late-Stage Asset To Australia-Based Firm	Benzinga
Tuesday, 19 April 2022
13:45	5 Top Biotech Penny Stocks Under $1 To Watch This Week	PennyStocks
11:17	Has Brickell Biotech (BBI) Outpaced Other Medical Stocks This Year?	Zacks Investment Research
Monday, 18 April 2022
12:38	Best Penny Stocks Today? 4 To Buy For Under $1 According To Reddit	PennyStocks
Thursday, 14 April 2022
13:37	Best Penny Stocks To Buy Now? 5 Stocks Under $1 To Watch In April	PennyStocks
Tuesday, 15 March 2022
14:39	Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q4 2021 Results - Earnings Call Transcript	Seeking Alpha
Tuesday, 8 March 2022
16:05	Brickell Biotech to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Corporate Update on March 15, 2022	GlobeNewsWire
Tuesday, 18 January 2022
12:57	Best High Volume Penny Stocks to Watch Right Now	PennyStocks
Tuesday, 9 November 2021
19:17	Brickell Biotech, Inc. (BBI) CEO Rob Brown on Q3 2021 Results - Earnings Call Transcript	Seeking Alpha
Wednesday, 27 October 2021
14:15	Penny Stocks That Will Explode? 3 For Your Watchlist	PennyStocks
Thursday, 7 October 2021
09:05	Brickell Biotech Aces Pivotal Sofpironium Trials In Patients With Excessive Underarm Sweating	Benzinga
06:55	Brickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Primary and Secondary Endpoints, from Both U.S. Phase 3 Pivotal Clinical Studies of Sofpironium Bromide Gel, 15% in Primary Axillary Hyperhidrosis Patients	GlobeNewsWire
Friday, 17 September 2021
08:00	Brickell Biotech to Host Key Opinion Leader Webinar on DYRK1A and its Role in Autoimmunity	GlobeNewsWire
Wednesday, 1 September 2021
12:23	Brickell Biotech Acquires Rights To Candidate For Autoimmune Diseases	Benzinga
07:05	Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer	GlobeNewsWire

Frequently Asked Questions (FAQ)

What's the price of Brickell Biotech stock today?

One share of Brickell Biotech stock can currently be purchased for approximately $2.35.
When is Brickell Biotech's next earnings date?

Unfortunately, Brickell Biotech's (BBI) next earnings date is currently unknown.
Does Brickell Biotech pay dividends?

No, Brickell Biotech does not pay dividends.
How much money does Brickell Biotech make?

Brickell Biotech has a market capitalization of 7.08M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 77.83% to 404K US dollars. Brickell Biotech made a loss 39.54M US dollars in net income (profit) last year or -$0.01 on an earnings per share basis.
What is Brickell Biotech's stock symbol?

Brickell Biotech, Inc. is traded on the NASDAQ under the ticker symbol "BBI".
What is Brickell Biotech's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Brickell Biotech?

Shares of Brickell Biotech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Brickell Biotech's key executives?
Brickell Biotech's management team includes the following people:
- Attorney Robert Busard Brown Chief Executive Officer & Director(age: 63, pay: $711,000)
- Mr. Andrew D. Sklawer Co-Founder, Chief Operating Officer & Sec.(age: 40, pay: $492,500)
- Mr. Deepak Chadha Chief R&D Officer(age: 55, pay: $479,830)
- Mr. Reginald L. Hardy M.B.A., R.Ph. Co-Founder & Chairman(age: 67, pay: $74,000)
Is Brickell Biotech founder-led company?

Yes, Brickell Biotech is a company led by its founders Mr. Andrew D. Sklawer and Mr. Reginald L. Hardy M.B.A., R.Ph..
How many employees does Brickell Biotech have?

As Jul 2024, Brickell Biotech employs 16 workers.
When Brickell Biotech went public?

Brickell Biotech, Inc. is publicly traded company for more then 32 years since IPO on 10 Mar 1993.
What is Brickell Biotech's official website?

The official website for Brickell Biotech is brickellbio.com.
Where are Brickell Biotech's headquarters?

Brickell Biotech is headquartered at 5777 Central Ave Ste 102, Boulder, COLORADO.
How can i contact Brickell Biotech?

Brickell Biotech's mailing address is 5777 Central Ave Ste 102, Boulder, COLORADO and company can be reached via phone at +1 720 505 4755.

Brickell Biotech, Inc.

brickellbio.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.

+1 720 505 4755

5777 Central Ave Ste 102
Boulder, COLORADO 80301

CIK: 0000819050
ISIN: US10802T1051
CUSIP: 10802T105